Factory 99% Levobupivacaine HCl Powder CAS 27262-48-2 Local Anesthetic Levobupivacaine HCl

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A256
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Levobupivacaine HCl
• CAS: 27262-48-2
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Local Anesthetic
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Levobupivacaine HCl
Appearance	White Powder
CAS NO.	27262-48-2
Molecular Formula	C18H29ClN2O
Storage	Keep in a cool, dry, dark location

 

Levobupivacaine HCl is a local anesthetic belonging to the amino amide class. It is an isomer of bupivacaine, specifically the left-handed enantiomer, and is primarily used for producing local anesthesia during surgical procedures and for pain management.

 

 

1. Regional Anesthesia: Levobupivacaine HCl is commonly used for regional anesthesia, including epidural anesthesia for obstetrics and surgery, peripheral nerve blocks, and caudal anesthesia.
2. Postoperative Pain Management: It can be administered via continuous infusion or bolus injection for postoperative pain management, providing long-lasting analgesia.
3. Pain Therapy: It is also used in pain therapy for the management of acute and chronic pain conditions, such as those associated with cancer, trauma, and neuropathic pain.

1. Local Anesthetic Action: Levobupivacaine HCl blocks the conduction of nerve impulses by reversibly binding to specific sites on sodium channels in the neuronal membrane, thereby inhibiting depolarization and blocking the initiation andof nerve impulses.
2. Duration of Action: It has a longer duration of action compared to some other local anesthetics, providing sustained anesthesia and analgesia.
3. Safety Profile: Being the pure left-handed enantiomer, Levobupivacaine HCl may have a more favorable safety profile with reduced cardiovascular toxicity compared to bupivacaine, although it should still be used with caution in patients with cardiovascular disease.